Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis

Endocrine Practice

Volumn 18, Issue 1, 2012, Pages

  Karanchi, Harsha ^a   Hamilton, Dale J ^a   Robbins, Richard J ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PERTECHNETIC ACID TC 99M; THYROTROPIN; THYROXINE;

ADULT; CANCER INVASION; CARCINOMA; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DYSPNEA; ECHOCARDIOGRAPHY; ECHOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENERALIZED EDEMA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HISTOPATHOLOGY; HUMAN; HURTHLE CELL CARCINOMA; HYPOKINESIA; JUGULAR VEIN; LUNG BLOOD VESSEL; NONISCHEMIC CARDIOMYOPATHY; PATIENT COMPLIANCE; PLEURA EFFUSION; RADIOGRAPHY; REVIEW; THYROIDECTOMY; THYROTOXICOSIS;

ADENOMA, OXYPHILIC; ADULT; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SODIUM PERTECHNETATE TC 99M; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; THYROTOXICOSIS;

EID: 84857609951     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11142.CR     Document Type: Review

References (21)

1. Wong CP, AuYong TK, Tong CM. Thyrotoxicosis: a rare presenting symptom of Hurthle cellcarcinoma of the thy-roid. Clin Nucl Med. 2003;28:803-806.
2. Har-El G, Hadar T, Segal K, Levy R, Sidi J. Hurthle cellcarcinoma of the thyroid gland. A tumor of moderate malig-nancy. Cancer. 1986;57:1613-1617.
3. Samaan NA, Maheshwari YK, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: ananalysis of 706 cases. J Clin Endocrinol Metab. 1983;56: 1131-1138.
4. Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF. Invasive Hürthle cellcarcinoma of the thyroid: naturalhistory and management. Mayo Clin Proc. 1984;59:851-855.
5. Dohán O, Baloch Z, Bánrévi Z, Livolsi V, Carrasco N. Rapid communication: predominant intracellular overex-pressionof the Na(+)/I(-) symporter (NIS) ina large sam-pling of thyroid cancer cases. J Clin Endocrinol Metab. 2001;86:2697-2700.
6. Caplan RH, Abellera RM, Kisken WA. Hürthle cellneo-plasms of the thyroid gland: reassessment of functionalcapacity. Thyroid. 1994;4:243-248.
7. De Keyser L, Layfield L, Van Herle A, Costin A, Lewin K. Biochemicaland immunohistochemicalcharacteriza-tionof proteins inHürthle cellcarcinoma. J Endocrinol Invest. 1984;7:449-454.
8. Gérard AC, Daumerie C, Mestdagh C, et al. Correlationbetweenthe loss of thyroglobuliniodinationand the expression of thyroid-specific proteins involved in iodine metabolism inthyroid carcinomas. J Clin Endocrinol Metab. 2003;88:4977-4983.
9. Rubenfeld S, Wheeler TM. Thyroid cancer presenting as a hot thyroid nodule: report of a case and review of the literature. Thyroidology. 1988:63-68.
10. Schröder S, Marthaler B. [Autonomy and malignancy of thyroid glad tumors. A criticalanalysis of the literature onthe existence of hyperfunctioning follicular and papillary thyroid gland carcinomas]. Pathologe. 1996;17:349-357.
11. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid can-cer. Endocrinol Metab Clin North Am. 1990;19:593-612.
12. Ashcraft MW, Van Herle AJ. Management of thyroid nodules. II: Scanning techniques, thyroid suppressive ther-apy, and fine needle aspiration. Head Neck Surg. 1981;3: 297-322.
13. Siddiqui AR, Karanauskas S. Hürthle cellcarcinoma inanautonomous thyroid nodule inanadolescent. Pediatr Radiol. 1995;25:568-569.
14. Russo D, Tumino S, Arturi F, et al. Detectionof anacti-vating mutationof the thyrotropinreceptor ina case of anautonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 1997;82:735-738.
15. Spambalg D, Sharifi N, Elisei R, Gross JL, Medeiros-Neto G, Fagin JA. Structuralstudies of the thyrotropinreceptor and Gs alpha inhumanthyroid cancers: low prevalence of mutations predicts infrequent involvement inmalignant transformation. J Clin Endocrinol Metab. 1996; 81:3898-3901.
16. Russo D, Wong MG, Costante G, et al. A Val677 activat-ing mutationof the thyrotropinreceptor ina Hürthle cellthyroid carcinoma associated with thyrotoxicosis. Thyroid. 1999;9:13-17.
17. Heimann P. Ultrastructure of HumanThyroid inThyrotoxicosis. InIrvine WJ, ed. Thyrotoxicosis: Proceedings of anInternationalSymposium. Baltimore, MD: Williams and Wilkins Co, 1967: 155-163.
18. Tremblay G, Pearse AG. Histochemistry of oxidative enzyme systems inthe humanthyroid, with specialreference to Askanazy cells. J Pathol Bacteriol. 1960;80:353-358.
19. Clark OH, Gerend PL. Thyrotropinreceptor-adenylate cyclase system inHurthle cellneoplasms. J Clin Endocrinol Metab. 1985;61:773-778.
20. Umpierrez GE, Challapalli S, Patterson C. Congestive heart failure due to reversible cardiomyopathy inpatients with hyperthyroidism. Am J Med Sci. 1995;310:99-102.
21. Dahl P, Danzi S, Klein I. Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008;5:170-176.